Loading...
Projects / Programmes
Biološke značilnosti raka glave in vratu in uspeh zdravljenja (Slovene)
Research activity
| Code | Science | Field | Subfield |
|---|---|---|---|
| 3.04.00 | Medical sciences | Oncology |
| Code | Science | Field |
|---|---|---|
| B007 | Biomedical sciences | Medicine (human and vertebrates) |
| B610 | Biomedical sciences | Otorhinolaryngology, audiology, auditive system and speech |
Keywords
Head and neck carcinoma, ploidy, proliferative activity, oncogenes, angiogenesis, postoperative irradiation, Mitomycin C, Bleomycin
Evaluation
(metodology)
Citations
Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
Organisations (2) , Researchers (11)
0302 Institute of Oncology Ljubljana
| no. | Code | Name and surname | Research area | Role | Period | No. of publicationsNo. of publications |
|---|---|---|---|---|---|---|
| 1. | 00702 | Oncology | Researcher | 2000 - 2002 | 128 | |
| 2. | 05318 | Oncology | Researcher | 2000 - 2002 | 351 | |
| 3. | 12224 | Oncology | Researcher | 2000 - 2002 | 82 | |
| 4. | 09762 | Oncology | Researcher | 2000 - 2002 | 125 | |
| 5. | 05316 | Oncology | Researcher | 2000 - 2002 | 52 | |
| 6. | 13156 | Oncology | Researcher | 2000 - 2002 | 275 | |
| 7. | 11747 | Oncology | Researcher | 2000 - 2002 | 435 |
0312 University Medical Centre Ljubljana
| no. | Code | Name and surname | Research area | Role | Period | No. of publicationsNo. of publications |
|---|---|---|---|---|---|---|
| 1. | 16048 | Oncology | Researcher | 2000 - 2002 | 113 | |
| 2. | 02130 | Oncology | Head | 2000 - 2002 | 218 | |
| 3. | 02132 | Oncology | Researcher | 2000 - 2002 | 394 | |
| 4. | 02133 | Oncology | Researcher | 2000 - 2002 | 78 |
Abstract
Authors intend to study correlation between the DNA ploidy, proliferative activity of tumor cells, expression of oncogenes and their products, tumor angiogenesis and treatment results of patients with head and neck carcinoma with poor prognostic factors. Al patients will be primarily operated on and postoperativly irradiated. Patients will be randimized so that a half of them will receive together with the postoperative irradiation also Mitomycin C and Bleomycin.